Functionality and Neurocognition in Patients With Bipolar Disorder After a Physical-Exercise Program (FINEXT-BD Study): Protocol of a Randomized Interventionist Program

Saínza García, Ilargi Gorostegi-Anduaga, Edurne García-Corres, Sara Maldonado-Martín, Karina S MacDowell, Cristina Bermúdez-Ampudia, María J Apodaca, Irene Pérez-Landaluce, Ignacio Tobalina-Larrea, Juan C Leza, A González-Pinto, Saínza García, Ilargi Gorostegi-Anduaga, Edurne García-Corres, Sara Maldonado-Martín, Karina S MacDowell, Cristina Bermúdez-Ampudia, María J Apodaca, Irene Pérez-Landaluce, Ignacio Tobalina-Larrea, Juan C Leza, A González-Pinto

Abstract

Introduction: Recent studies have shown that symptoms of psychiatric illness, functionality, and cognitive function improve with exercise. The aim of this study will be to investigate whether the implementation of an individualized exercise program will improve the functional status of patients with bipolar disorder (BD). Methods: This longitudinal, interventional, randomized, controlled, simple-blind clinical trial will include 80 patients aged 18-65 years, all of them with BD diagnosis. Patients will be randomly assigned to a physical exercise intervention + Treatment-As-Usual (TAU) group and a non-intervention + TAU group. Patients will be assessed by an extensive battery of clinical tests, physical parameters (e.g., brain structure changes measured by optical coherence tomography, cardiorespiratory fitness) and biological parameters (inflammation, oxidative stress and neurotrophic factors) at baseline, after a 4-month intervention period, and 6-month follow-up. Discussion: This is an innovative study aimed at gaining a deeper understanding of the physiopathology of BD and determining whether the prognosis and evolution of the disease can be improved through modifiable areas of the patient's lifestyle. Clinical Trial Registration: NCT04400630. NCT clinicaltrials.gov. Date of registration in primary registry 22 May 2020. clinicaltrials.gov.

Keywords: bipolar disorder; functional capacity; intervention program; neurocognition; physical exercise.

Copyright © 2020 García, Gorostegi-Anduaga, García-Corres, Maldonado-Martín, MacDowell, Bermúdez-Ampudia, Apodaca, Pérez-Landaluce, Tobalina-Larrea, Leza and González-Pinto.

Figures

Figure 1
Figure 1
FINEXT-BD study procedure.

References

    1. World Health Organization Mental Disorder Fact Sheet. WHO (2016).
    1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV-TR). Washington, DC: American Psychiatric Association; (2000).
    1. Anderson IM, Haddad PM, Scott J. Bipolar disorder. BMJ. (2012) 345:e8508 10.1136/bmj.e8508
    1. Chatterton ML, Stockings E, Berk M, Barendregt JJ, Carter R, Mihalopoulos C. Psychosocial therapies for the adjunctive treatment of bipolar disorder in adults: network meta-analysis. Br J Psychiatry. (2017) 210:333–41. 10.1192/bjp.bp.116.195321
    1. Duman RS. Neurobiology of stress, depression, and rapid acting antidepressants: remodeling synaptic connections. Depress Anxiety. (2014) 31:291–6. 10.1002/da.22227
    1. Moylan S, Eyre HA, Maes M, Baune BT, Jacka FN, Berk M. Exercising the worry away: how inflammation, oxidative and nitrogen stress mediates the beneficial effect of physical activity on anxiety disorder symptoms and behaviours. Neurosci Biobehav Rev. (2013) 37:573–84. 10.1016/j.neubiorev.2013.02.003
    1. Vancampfort D, Hallgren M, Firth J, Rosenbaum S, Schuch FB, Mugisha J, et al. . Physical activity and suicidal ideation: a systematic review and meta-analysis. J Affect Disord. (2018) 225:438–48. 10.1016/j.jad.2017.08.070
    1. Phillips C. Physical activity modulates common neuroplasticity substrates in major depressive and bipolar disorder. Neural Plast. (2017) 2017:7014146. 10.1155/2017/7014146
    1. Engh JA, Andersen E, Holmen TL, Martinsen EW, Mordal J, Morken G, et al. . Effects of high-intensity aerobic exercise on psychotic symptoms and neurocognition in outpatients with schizophrenia: study protocol for a randomized controlled trial. Trials. (2015) 16:557. 10.1186/s13063-015-1094-2
    1. Fernandes BS, Molendijk ML, Köhler CA, Soares JC, Leite CMGS, Machado-Vieira R, et al. . Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker in bipolar disorder: a meta-analysis of 52 studies. BMC Med. (2015) 13:289. 10.1186/s12916-015-0529-7
    1. Soares AT, Andreazza AC, Rej S, Rajji TK, Gildengers AG, Lafer B, et al. . Decreased brain-derived neurotrophic factor in older adults with bipolar disorder. Am J Geriatr Psychiatry. (2016) 24:596–601. 10.1016/j.jagp.2016.02.052
    1. Matrisciano F, Bonaccorso S, Ricciardi A, Scaccianoce S, Panaccione I, Wang L, et al. Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine. J Psychiatr Res. (2009) 43:247–54. 10.1016/j.jpsychires.2008.03.014
    1. Brunoni AR, Lopes M, Fregni F. A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. Int J Neuropsychopharmacol. (2008) 11:1169–80. 10.1017/S1461145708009309
    1. Martinez-Cengotitabengoa M, MacDowell KS, Alberich S, Diaz FJ, Garcia-Bueno B, Rodriguez-Jimenez R, et al. . BDNF and NGF signalling in early phases of psychosis: relationship with inflammation and response to antipsychotics after 1 year. Schizophr Bull. (2016) 42:142–51. 10.1093/schbul/sbv078
    1. Wong J, Rothmond DA, Webster MJ, Weickert CS. Increases in two truncated TrkB isoforms in the prefrontal cortex of people with schizophrenia. Schizophr Bull. (2013) 39:130–40. 10.1093/schbul/sbr070
    1. García-Álvarez L, Caso JR, García-Portilla MP, de la Fuente-Tomás L, González-Blanco L, Sáiz Martínez P, et al. . Regulation of inflammatory pathways in schizophrenia: a comparative study with bipolar disorder and healthy controls. Eur Psychiatry. (2018) 47:50–9. 10.1016/j.eurpsy.2017.09.007
    1. Kucyi A, Alsuwaidan MT, Liauw SS, McIntyre RS. Aerobic physical exercise as a possible treatment for neurocognitive dysfunction in bipolar disorder. Postgrad Med. (2010) 122:107–16. 10.3810/pgm.2010.11.2228
    1. Melo MCA, Daher EDF, Albuquerque SGC, de Bruin VMS. Exercise in bipolar patients: a systematic review. J Affect Disord. (2016) 198:32–8. 10.1016/j.jad.2016.03.004
    1. Khalil MA, Saleh AA, Gohar SM, Khalil DH, Said M. Optical coherence tomography findings in patients with bipolar disorder. J Affect Disord. (2017) 218:115–22. 10.1016/j.jad.2017.04.055
    1. Celik M, Kalenderoglu A, Sevgi Karadag A, Bekir Egilmez O, Han-Almis B, Simşek A. Decreases in ganglion cell layer and inner plexiform layer volumes correlate better with disease severity in schizophrenia patients than retinal nerve fiber layer thickness: findings from spectral optic coherence tomography. Eur Psychiatry. (2016) 32:9–15. 10.1016/j.eurpsy.2015.10.006
    1. Lee WW, Tajunisah I, Sharmilla K, Peyman M, Subrayan V. Retinal nerve fiber layer structure abnormalities in schizophrenia and its relationship to disease state: evidence from optical coherence tomography. Investigative Ophthalmol Visual Sci. (2013) 54:7785–92. 10.1167/iovs.13-12534
    1. Schönfeldt-Lecuona C, Kregel T, Schmidt A, Pinkhardt EH, Lauda F, Kassubek J, et al. . From imaging the brain to imaging the retina: optical coherence tomography (OCT) in schizophrenia. Schizophr Bull. (2016) 42:9–14. 10.1093/schbul/sbv073
    1. Chu EM-Y, Kolappan M, Barnes TRE, Joyce EM, Ron MA. A window into the brain: an in vivo study of the retina in schizophrenia using optical coherence tomography. Psychiatry Res. (2012) 203:89–94. 10.1016/j.pscychresns.2011.08.011
    1. Adams SA, Nasrallah HA. Multiple retinal anomalies in schizophrenia. Schizophr Res. (2018) 195:3–12. 10.1016/j.schres.2017.07.018
    1. Frohman EM, Fujimoto JG, Frohman TC, Calabresi PA, Cutter G, Balcer LJ. Optical coherence tomography: a window into the mechanisms of multiple sclerosis. Nat Clin Pract Neurol. (2008) 4:664–75. 10.1038/ncpneuro0950
    1. Cetin EN, Bir LS, Sarac G, Yaldizkaya F, Yaylali V. Optic disc and retinal nerve fibre layer changes in parkinson's disease. Neuro Ophthalmol. (2013) 37:20–3. 10.3109/01658107.2012.757788
    1. Lu Y, Li Z, Zhang X, Ming B, Jia J, Wang R, et al. Retinal nerve fiber layer structure abnormalities in early Alzheimer's disease: evidence in optical coherence tomography. Neurosci Lett. (2010) 480:69–72. 10.1016/j.neulet.2010.06.006
    1. Saidha S, Syc SB, Ibrahim MA, Eckstein C, Warner CV, Farrell SK, et al. . Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. Brain. (2011) 134(Pt 2): 518–33. 10.1093/brain/awq346
    1. Schönfeldt-Lecuona C, Kregel T, Schmidt A, Kassubek J, Dreyhaupt J, Freudenmann RW, et al. . Retinal single-layer analysis with optical coherence tomography (OCT) in schizophrenia spectrum disorder. Schizophr Res. (2019) 219:5–12. 10.1016/j.schres.2019.03.022
    1. Stanton R, Reaburn P. Exercise and the treatment of depression: a review of the exercise program variables. J Sci Med Sport. (2014) 17:177–82. 10.1016/j.jsams.2013.03.010
    1. American Psychiatric Association Diagnostic and statistical manual of mental disorders 5th ed Washington, DC: American Psychiatric Association; (2013). 10.1176/appi.books.9780890425596
    1. First M, Spitzer R, Gibbon M, Williams J. Entrevista Clínica Estructurada Para los Trastornos del eje-I del DSM-IV. Barcelona: Masson; (1999).
    1. World Health Organization Global Physical Activity Questionnaire (GPAQ). Available online at: (accessed March 6, 2020).
    1. Zabetian A, Hadaegh F, Azizi F. Prevalence of metabolic syndrome in Iranian adult population, concordance between the IDF with the ATPIII and the WHO definitions. Diabetes Res Clin Pract. (2007) 77:251–7. 10.1016/j.diabres.2006.12.001
    1. Mezzani A, Hamm LF, Jones AM, McBride PE, Moholdt T, Stone JA, et al. . Aerobic exercise intensity assessment and prescription in cardiac rehabilitation: a joint position statement of the European association for cardiovascular prevention and rehabilitation, the American association of cardiovascular and pulmonary rehabilitation and the Canadian association of cardiac rehabilitation. Eur J Prev Cardiol. (2013) 20:442–67. 10.1177/2047487312460484
    1. Task Force of the Italian Working Group on Cardiac Rehabilitation and Prevention (Gruppo Italiano di Cardiologia Riabilitativa e Prevenzione, GICR), Working Group on Cardiac Rehabilitation and Exercise Physiology of the European Society of Cardiology. Piepoli MF, Corrà U, Agostoni PG, Belardinelli R, et al. Statement on cardiopulmonary exercise testing in chronic heart failure due to left ventricular dysfunction: recommendations for performance and interpretation Part II: how to perform cardiopulmonary exercise testing in chronic heart failure. Eur J Cardiovasc Prev Rehabil. (2006) 13:300–11. 10.1097/01.hjr.0000199493.39085.e5
    1. Harris JG. An abbreviated form of the Phillips rating scale of premorbid adjustment in schizophrenia. J Abnorm Psychol. (1975) 84:129–37. 10.1037/h0076983
    1. Rosa AR, Sánchez-Moreno J, Martínez-Aran A, Salamero M, Torrent C, Reinares M, et al. . Validity and reliability of the functioning assessment short test (FAST) in bipolar disorder. Clin Pract Epidemiol Ment Health. (2007) 3:5. 10.1186/1745-0179-3-5
    1. Kavitha RR, Kamalam S, Rajkumar RP. Functional ability of clients with bipolar disorders in tertiary hospital, Puducherry. Int J Community Based Nurs Midwifery. (2018) 6:21–8.
    1. Endicott J, Spitzer RL, Fleiss JL, Cohen J. The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry. (1976) 33:766–71. 10.1001/archpsyc.1976.01770060086012
    1. Strauss JS, Carpenter WT. The prediction of outcome in schizophrenia. I. Characteristics of outcome. Arch Gen Psychiatry. (1972) 27:739–46. 10.1001/archpsyc.1972.01750300011002
    1. Alberich S, Barbeito S, González-Ortega I, Ugarte A, Vega P, de Azúa SR, et al. . Psychometric properties and validation of a four-item version of the Strauss–Carpenter scale in bipolar disorder. Int J Bipolar Disord. (2016) 4:22. 10.1186/s40345-016-0063-3
    1. Stroop JR. Studies of interference in serial verbal reactions. J Exp Psychol. (1935) 18:643–62. 10.1037/h0054651
    1. Scarpina F, Tagini S. The stroop color and word test. Front Psychol. (2017) 8:557. 10.3389/fpsyg.2017.00557
    1. Benedet MJ, Alejandre MA. Manual del Test de Aprendizaje Verbal España Complutense (TAVEC). Madrid: Ediciones TEA; (1998).
    1. Delis DC, Freeland J, Kramer JH, Kaplan E. Integrating clinical assessment with cognitive neuroscience: construct validation of the California verbal learning test. J Consult Clin Psychol. (1988) 56:123–30. 10.1037/0022-006X.56.1.123
    1. Ibanez-Casas I, De Portugal E, Gonzalez N, McKenney KA, Haro JM, Usall J, et al. . Deficits in executive and memory processes in delusional disorder: a case-control study. PLoS ONE. (2013) 8:e67341. 10.1371/journal.pone.0067341
    1. Heaton RK. ST-64:CV Computer Version for Windows Research Edition. Odessa, FL: Psychological Assessment Resources; (2000).
    1. Lezak M. Neuropsychological Assessment. 4th ed New York, NY: Oxford University Press; (2004).
    1. Kopp B, Maldonado N, Scheffels JF, Hendel M, Lange F. A meta-analysis of relationships between measures of wisconsin card sorting and intelligence. Brain Sci. (2019) 9:349. 10.3390/brainsci9120349
    1. Guy W. Early Clinical Drug Evaluation Unit (ECDEU) Assessment Manual for Psychopharmacology. Rockville, MD: National Institute of Mental Health: US Department of Health, Education, and Welfare Publication (ADM) (1976).
    1. Lindenmayer JP, Czobor P, Alphs L, Nathan A-M, Anand R, Islam Z, et al. . The interSePT scale for suicidal thinking reliability and validity. Schizophr Res. (2003) 63:161–70. 10.1016/S0920-9964(02)00335-3
    1. Amador XF, Strauss DH, Yale SA, Flaum MM, Endicott J, Gorman JM. Assessment of insight in psychosis. Am J Psychiatry. (1993) 150:873–9. 10.1176/ajp.150.6.873
    1. Michel P, Baumstarck K, Auquier P, Amador X, Dumas R, Fernandez J, et al. . Psychometric properties of the abbreviated version of the scale to assess unawareness in mental disorder in schizophrenia. BMC Psychiatry. (2013) 13:229. 10.1186/1471-244X-13-229
    1. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. (1986) 24:67–74. 10.1097/00005650-198601000-00007
    1. Grof P, Duffy A, Cavazzoni P, Grof E, Garnham J, MacDougall M, et al. . Is response to prophylactic lithium a familial trait? J Clin Psychiatry. (2002) 63:942–7. 10.4088/JCP.v63n1013
    1. Woo YS, Yoon B-H, Song J-H, Seo JS, Nam B, Lee K, et al. Clinical correlates associated with the long-term response of bipolar disorder patients to lithium, valproate or lamotrigine: a retrospective study. PLoS ONE. (2020) 15:e0227217 10.1371/journal.pone.0227217
    1. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. (1967) 6:278–96. 10.1111/j.2044-8260.1967.tb00530.x
    1. Bech P. The Bech, Hamilton and Zung Scales for Mood Disorders: Screening and Listening: A Twenty Years Update with Reference to DSM-IV and ICD-10. 2nd ed Berlin Heidelberg: Springer-Verlag; (1996). 10.1007/978-3-642-61169-8
    1. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. (1978) 133:429–35. 10.1192/bjp.133.5.429
    1. The WHOQOL Group . Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med. (1998) 28:551–8.
    1. Kokkevi A, Hartgers C. EuropASI: European adaptation of a multidimensional assessment instrument for drug and alcohol dependence. Eur Addict Res. (1995) 1:208–10. 10.1159/000259089
    1. Giglio LMF, da Silva Magalhães PV, Andreazza AC, Walz JC, Jakobson L, Rucci P, et al. . Development and use of a biological rhythm interview. J Affect Disord. (2009) 118:161–5. 10.1016/j.jad.2009.01.018
    1. Palagini L, Miniati M, Caruso D, Massa L, Novi M, Pardini F, et al. . Association between affective temperaments and mood features in bipolar disorder II: the role of insomnia and chronobiological rhythms desynchronization. J Affect Disord. (2020) 266:263–72. 10.1016/j.jad.2020.01.134
    1. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Analyt Biochem. (1982) 126:131–8. 10.1016/0003-2697(82)90118-X
    1. Moselhy HF, Reid RG, Yousef S, Boyle SP. A specific, accurate, and sensitive measure of total plasma malondialdehyde by HPLC. J Lipid Res. (2013) 54:852–8. 10.1194/jlr.D032698
    1. Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-Evans C. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radical Biol Med. (1999) 26:1231–7. 10.1016/S0891-5849(98)00315-3
    1. Schreiber E, Matthias P, Müller MM, Schaffner W. Rapid detection of octamer binding proteins with “mini-extracts”, prepared from a small number of cells. Nucleic Acids Res. (1989) 17:6419. 10.1093/nar/17.15.6419
    1. Maldonado-Martín S, Gorostegi-Anduaga I, Aispuru GR, Illera-Villas M, Jurio-Iriarte B, Francisco-Terreros S, et al. Effects of different aerobic exercise programs with nutritional intervention in primary hypertensive and overweight/obese adults: EXERDIET-HTA controlled trial. J Clin Trials. (2016) 6:1 10.4172/2167-0870.1000252
    1. Maldonado-Martín S, Jayo-Montoya JA, Matajira-Chia T, Villar-Zabala B, Goiriena JJ, Aispuru GR. Effects of combined high-intensity aerobic interval training program and mediterranean diet recommendations after myocardial infarction (INTERFARCT Project): study protocol for a randomized controlled trial. Trials. (2018) 19:156. 10.1186/s13063-018-2529-3
    1. Choi KW, Chen C-Y, Stein MB, Klimentidis YC, Wang M-J, Koenen KC, et al. . Assessment of bidirectional relationships between physical activity and depression among adults: A 2-sample mendelian randomization study. JAMA Psychiatry. (2019) 76:399–408. 10.1001/jamapsychiatry.2018.4175
    1. Kubesch S, Bretschneider V, Freudenmann R, Weidenhammer N, Lehmann M, Spitzer M, et al. . Aerobic endurance exercise improves executive functions in depressed patients. J Clin Psychiatry. (2003) 64:1005–12. 10.4088/JCP.v64n0905
    1. Greer TL, Grannemann BD, Chansard M, Karim AI, Trivedi MH. Dose-dependent changes in cognitive function with exercise augmentation for major depression: results from the TREAD study. Eur Neuropsychopharmacol. (2015) 25:248–56. 10.1016/j.euroneuro.2014.10.001
    1. Strassnig MT, Signorile JF, Potiaumpai M, Romero MA, Gonzalez C, Czaja S, et al. . High velocity circuit resistance training improves cognition, psychiatric symptoms and neuromuscular performance in overweight outpatients with severe mental illness. Psychiatry Res. (2015) 229:295–301. 10.1016/j.psychres.2015.07.007
    1. MacQueen GM, Memedovich KA. Cognitive dysfunction in major depression and bipolar disorder: assessment and treatment options. Psychiatry Clin Neurosci. (2017) 71:18–27. 10.1111/pcn.12463
    1. Volkert J, Kopf J, Kazmaier J, Glaser F, Zierhut KC, Schiele MA, et al. . Evidence for cognitive subgroups in bipolar disorder and the influence of subclinical depression and sleep disturbances. Eur Neuropsychopharmacol. (2015) 25:192–202. 10.1016/j.euroneuro.2014.07.017
    1. Sanchez-Moreno J, Bonnín C, González-Pinto A, Amann BL, Solé B, Balanzá-Martínez V, et al. . Do patients with bipolar disorder and subsyndromal symptoms benefit from functional remediation? A 12-month follow-up study. Eur Neuropsychopharmacol. (2017) 27:350–9. 10.1016/j.euroneuro.2017.01.010
    1. Penadés R, López-Vílchez I, Catalán R, Arias B, González-Rodríguez A, García-Rizo C, et al. . BDNF as a marker of response to cognitive remediation in patients with schizophrenia: a randomized and controlled trial. Schizophr Res. (2018) 197:458–64. 10.1016/j.schres.2017.12.002

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren